Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
Episodes
Monday Nov 27, 2023
Monday Nov 27, 2023
touchCONGRESS for touchONCOLOGY
Listen to renowned prostate cancer expert Prof. Oliver Sartor review key data presented at the recent EMSO 2023 congress on new and emerging data that addresses key clinical questions on the use of radiopharmaceuticals in advanced prostate cancer. He also discusses with two additional leading experts, Prof. Francesco Ceci and Dr Heather Jacene, how these data may apply in clinical practice.
Overview
- Data reviews with Prof. Oliver Sartor
- Expert panel discussions with Prof. Francesco Ceci and Dr Heather Jacene on the themes below
Clinical themes
- Refining the use of PSMA-targeted radiopharmaceuticals through optimal patient selections
- Expanding the use of PSMA-targeting radiopharmaceuticals in prostate cancer
- Novel agents and combination approaches to the use of PSMA-targeted radiopharmaceuticals in prostate cancer
The internationally renowned expert faculty
- Prof. Oliver Sartor, Mayo Clinic, Rochester, MN, USA
- Prof. Francesco Ceci, European Institute of Oncology, IRCCS, Milan, Italy
- Dr Heather Jacene, Dana-Farber Cancer Institute, Boston, MA, USA
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Advanced Accelerator Applications, and is jointly provided by USF Health and touchIME.
For further information visit our website: touchoncologyime.org/psma-targeted-radiopharmaceuticals-an-evolving-approach-to-prostate-cancer-management/
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.